ADVISORY RESEARCH INC - HARMONY BIOSCIENCES HLDGS IN ownership

Back to all holdings Add to watchlist

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q2 2022$2,118,000
-0.3%
43,430
-0.5%
0.21%
+21.8%
Q1 2022$2,124,000
+59.8%
43,670
+40.1%
0.17%
+61.9%
Q4 2021$1,329,000
-70.9%
31,170
-73.8%
0.10%
-64.2%
Q3 2021$4,563,000–119,050–0.29%–
 Download
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders